TNXP
insider transactionsTonix Pharmaceuticals Holding Corp. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 3 different insiders made open-market purchases in the last 90 days, totalling $195.2K.
Net shares · 90d
+16.4K
16.4K buy · 0 sell
Net value · 90d
$195.2K
$195.2K in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
4
16.4K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$14.9K
1.4K sh · $10.55
Own +339%
-
Buy·P
Seth Lederman KEY
Chief Executive Officer
$59.0K
5.0K sh · $11.79
Own +125%
-
Buy·P
Director
$58.2K
5.0K sh · $11.65
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Grant·A
Director
$0
22.7K sh
Own New
-
Buy·P
Seth Lederman KEY
Chief Executive Officer
$63.1K
5.0K sh · $12.62
Own +33%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Carolyn E. Taylor | Buy P | 1.4K | $14.9K |
| Jun 9, 2026 | Seth Lederman KEY | Buy P | 5.0K | $59.0K |
| Jun 8, 2026 | Richard Newcomb Stillwell | Buy P | 5.0K | $58.2K |
| May 12, 2026 | James Treco | Grant A | 22.7K | $0 |
| May 12, 2026 | Carolyn E. Taylor | Grant A | 22.7K | $0 |
| May 12, 2026 | Richard Newcomb Stillwell | Grant A | 22.7K | $0 |
| May 12, 2026 | Adeoye Y Olukotun | Grant A | 22.7K | $0 |
| May 12, 2026 | James Randolph Hunter Jr | Grant A | 22.7K | $0 |
| May 12, 2026 | David L Grange | Grant A | 22.7K | $0 |
| May 12, 2026 | Margaret Smith Bell | Grant A | 22.7K | $0 |
| May 12, 2026 | Richard H Bagger | Grant A | 22.7K | $0 |
| Mar 31, 2026 | Seth Lederman KEY | Buy P | 5.0K | $63.1K |
About TNXP insider trading
This page tracks insider transactions for Tonix Pharmaceuticals Holding Corp. (TNXP) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.